19010842

Source:http://linkedlifedata.com/resource/pubmed/id/19010842

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0013089, umls-concept:C0016360, umls-concept:C0027651, umls-concept:C0123931, umls-concept:C0205314, umls-concept:C0542341, umls-concept:C0679622, umls-concept:C1704711, umls-concept:C1801960, umls-concept:C2349975
pubmed:issue	22
pubmed:dateCreated	2008-11-17
pubmed:abstractText	To examine the antitumor effects of Irinophore C, a nanopharmaceutical formulation of irinotecan, on the tissue morphology and function of tumor vasculature in HT-29 human colorectal tumors.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9502500
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Fluorouracil, http://linkedlifedata.com/resource/pubmed/chemical/Liposomes, http://linkedlifedata.com/resource/pubmed/chemical/Nanocapsules, http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	1078-0432
pubmed:author	pubmed-author:AdamMichael JMJ, pubmed-author:AnanthaMalathiM, pubmed-author:BakerJennifer H EJH, pubmed-author:BallyMarcel BMB, pubmed-author:CoSteven JSJ, pubmed-author:DragowskaWieslawa HWH, pubmed-author:KozlowskiPiotrP, pubmed-author:KyleAlaistair HAH, pubmed-author:LamJeffreyJ, pubmed-author:MinchintonAndrew IAI, pubmed-author:NgSylvia S WSS, pubmed-author:OliverThomasT, pubmed-author:RamsayEuanE, pubmed-author:RuthThomas JTJ, pubmed-author:SyJonathanJ, pubmed-author:YappDonald T TDT, pubmed-author:YungAndrewA
pubmed:issnType	Print
pubmed:day	15
pubmed:volume	14
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	7260-71
pubmed:meshHeading	pubmed-meshheading:19010842-Animals, pubmed-meshheading:19010842-Antineoplastic Agents, pubmed-meshheading:19010842-Camptothecin, pubmed-meshheading:19010842-Cell Hypoxia, pubmed-meshheading:19010842-Doxorubicin, pubmed-meshheading:19010842-Fluorouracil, pubmed-meshheading:19010842-Humans, pubmed-meshheading:19010842-Image Processing, Computer-Assisted, pubmed-meshheading:19010842-Immunohistochemistry, pubmed-meshheading:19010842-Liposomes, pubmed-meshheading:19010842-Magnetic Resonance Imaging, pubmed-meshheading:19010842-Magnetic Resonance Spectroscopy, pubmed-meshheading:19010842-Mice, pubmed-meshheading:19010842-Nanocapsules, pubmed-meshheading:19010842-Neoplasms, Experimental, pubmed-meshheading:19010842-Neovascularization, Pathologic, pubmed-meshheading:19010842-Tissue Distribution, pubmed-meshheading:19010842-Xenograft Model Antitumor Assays
pubmed:year	2008
pubmed:articleTitle	Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin.
pubmed:affiliation	Medical Biophysics, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't